ORIGINAL ARTICLE

Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma

I Esposito¹, M Menicagli², N Funel², F Bergmann¹, U Boggi³, F Mosca³, G Bevilacqua² and D Campani²

¹ Institute of Pathology, University of Heidelberg, 69120 Heidelberg, Germany
² Department of Oncology, Transplantation and Advanced Technologies in Medicine, Division of Surgical, Molecular and Ultrastructural Pathology, University of Pisa, Pisa 56100, Italy
³ Department of Oncology, Transplantation and Advanced Technologies in Medicine, Division of General and Transplantation Surgery, University of Pisa

Correspondence to:
Correspondence to:
Dr I Esposito
Institute of Pathology, University of Heidelberg, Im Neuenheimer Feld 220, 69120 Heidelberg, Germany; irene_esposito{at}med.uni-heidelberg.de

Background: Inflammatory cells contribute to the growth and spread of human malignancies by producing molecules that enhance tumour invasiveness.

Aims: To characterise the inflammatory infiltrate in pancreatic ductal adenocarcinoma and to analyse its contribution to angiogenesis and its prognostic relevance.

Methods: Immunohistochemistry was used to identify inflammatory cells and evaluate the expression of proangiogenic and prolymphangiogenic molecules (vascular endothelial growth factor A (VEGF-A), VEGF-C, and basic fibroblast growth factor (bFGF)) by inflammatory and cancer cells in 137 pancreatic cancers. Intratumorous microvessel density (IMD) was assessed using CD34 as an endothelial cell marker.

Results: There were significantly more mast cells and macrophages in pancreatic cancers than in normal pancreas and the number of mast cells directly correlated with the presence of lymph node metastases. However, there was no relation between numbers of infiltrating inflammatory cells and the presence of chronic pancreatitis (CP)-like changes in the parenchyma surrounding the tumour. Double immunostaining revealed that both pancreatic mast cells and macrophages express VEGF-A, VEGF-C, and bFGF. These factors were also expressed in the tumour cells in many cases. The numbers of VEGF-A expressing tumour cells and bFGF expressing tumour and inflammatory cells significantly correlated with IMD. Moreover, tumours with higher IMD had higher numbers of infiltrating mast cells and macrophages.

Conclusions: Mononuclear inflammatory cells of the non-specific immune response are recruited to pancreatic cancer tissues independent of the presence of CP-like changes, may influence the metastatic capacity of the cancer cells, and may contribute to the development of tumours with high angiogenic activity.

Keywords: pancreatic cancer; mast cells; macrophages; angiogenesis; tryptase

Abbreviations: bFGF, basic fibroblast growth factor; CSF, colony stimulating factor 1; IMD, intratumorous microvessel density; VEGF, vascular endothelial growth factor

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Seeliger, H., Camaj, P., Ischenko, I., Kleespies, A., De Toni, E. N., Thieme, S. E., Blum, H., Assmann, G., Jauch, K.-W., Bruns, C. J. (2009). EFEMP1 Expression Promotes In vivo Tumor Growth in Human Pancreatic Adenocarcinoma. Mol Cancer Res 7: 189-198 [Abstract] [Full Text]  
• Fischbach, C., Kong, H. J., Hsiong, S. X., Evangelista, M. B., Yuen, W., Mooney, D. J. (2009). Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc. Natl. Acad. Sci. USA 106: 399-404 [Abstract] [Full Text]  
• Tassi, E., Gavazzi, F., Albarello, L., Senyukov, V., Longhi, R., Dellabona, P., Doglioni, C., Braga, M., Di Carlo, V., Protti, M. P. (2008). Carcinoembryonic Antigen-Specific but Not Antiviral CD4+ T Cell Immunity Is Impaired in Pancreatic Carcinoma Patients. J. Immunol. 181: 6595-6603 [Abstract] [Full Text]  
• Theoharides, T. C. (2008). Mast Cells and Pancreatic Cancer. NEJM 358: 1860-1861 [Full Text]  
• Brideau, G., Makinen, M. J., Elamaa, H., Tu, H., Nilsson, G., Alitalo, K., Pihlajaniemi, T., Heljasvaara, R. (2007). Endostatin Overexpression Inhibits Lymphangiogenesis and Lymph Node Metastasis in Mice. Cancer Res. 67: 11528-11535 [Abstract] [Full Text]  
• Gounaris, E., Erdman, S. E., Restaino, C., Gurish, M. F., Friend, D. S., Gounari, F., Lee, D. M., Zhang, G., Glickman, J. N., Shin, K., Rao, V. P., Poutahidis, T., Weissleder, R., McNagny, K. M., Khazaie, K. (2007). Mast cells are an essential hematopoietic component for polyp development. Proc. Natl. Acad. Sci. USA 104: 19977-19982 [Abstract] [Full Text]  
• Mahadevan, D., Von Hoff, D. D. (2007). Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Molecular Cancer Therapeutics 6: 1186-1197 [Abstract] [Full Text]  
• Dirkx, A. E. M., oude Egbrink, M. G. A., Wagstaff, J., Griffioen, A. W. (2006). Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J. Leukoc. Biol. 80: 1183-1196 [Abstract] [Full Text]  
• Duell, E. J., Casella, D. P., Burk, R. D., Kelsey, K. T., Holly, E. A. (2006). Inflammation, Genetic Polymorphisms in Proinflammatory Genes TNF-A, RANTES, and CCR5, and Risk of Pancreatic Adenocarcinoma.. Cancer Epidemiol. Biomarkers Prev. 15: 726-731 [Abstract] [Full Text]  
• Jin, H., Su, J., Garmy-Susini, B., Kleeman, J., Varner, J. (2006). Integrin {alpha}4{beta}1 Promotes Monocyte Trafficking and Angiogenesis in Tumors. Cancer Res. 66: 2146-2152 [Abstract] [Full Text]  
• Udagawa, T., Puder, M., Wood, M., Schaefer, B. C., D'Amato, R. J. (2006). Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells. FASEB J. 20: 95-102 [Abstract] [Full Text]